Back
ESC Premium Access

Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability

Session: Poster Session 1 - Atherosclerosis and vascular dysfunction
Topic: Vascular Diseases: Fibrosis
Speaker: Doctor S. Stein (Zurich, CH)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Sokrates Stein

University of Zurich, Zurich (Switzerland)
0 follower

12 more presentations in this session

Endothelial function and testosterone deficiency in men with type 2 diabetes mellitus

Speaker: Associate Professor I. Khripun (Rostov-on-Don, RU)

Access
Abstract
Slides
Like
Thumbnail

Identification of 26 novel loci that confer susceptibility to early-onset coronary artery disease in a Japanese population

Speaker: Doctor M. Oguri (Kasugai, JP)

Access
Abstract
Slides
Like
Thumbnail

Improvement in endothelial function and arterial elastic properties facilitates response to cardiac resynchronization therapy

Speaker: Doctor N. Karamichalakis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

S100A4, a key player in plaque stabilization?

Speaker: Miss A. Sakic (Geneva, CH)

Access
Abstract
Like
Thumbnail

Histamine promotes atherosclerotic plaque instability via STAT6-dependent macrophage pyroptosis

Speaker: Doctor L. Xu (Shanghai, CN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Atherosclerosis and vascular dysfunction

Speakers: Doctor S. Stein, Associate Professor I. Khripun, Doctor M. Oguri, Doctor N. Karamichalakis, Miss A. Sakic...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources